NAT as part of routine tests ? I disagree ! Dr Anjali Arun Mysore.

Slides:

Advertisements

Similar presentations

Guidance Notes on Safe Health Facilities Sanjaya Bhatia Focal Point Disaster Resilient Schools & Hospitals.

Advertisements

HIV/ AIDS - Yemen Successes and challenges Dr. Fouzia Abdullah Gharama Programme Manager Ministry of Public Health & Population.

Public health & Globalisation Dr. Babar T Shaikh The Aga Khan University Karachi, Pakistan.

February Dakar, Senegal

Lessons Learned in Social Protection in health Group 8.

An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.

An Introduction to Expenditure Analysis ~ an overview of the NASA methodology Teresa Guthrie Centre for Economic Governance and AIDS in Africa OSI Workshop,

Susan N. Hocevar, MD Medical Officer Office of Blood, Organ, and Other Tissue Safety Division of Healthcare Quality and Promotion Investigation Framework.

Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:

F. Kourgia, M. Vini, E. Zervou

Treviso, 21 October Karin Magnussen. Donors outside the Blood Bank /Centre Donors in the Blood Bank /Centre Blood products Blood Group serology The Patients.

Health Care Financing in Pakistan: Trends and Issues

CHALLENGES IN DONOR RECRUITMENT IN THIRD WORLD COUNTRIES, ( THE CASE OF KENYA)

Management of Risk and Blood Availability in Donor Populations with High Prevalence of Blood Borne Pathogens Ravi Reddy IBSF Meeting 20 March 2015.

Blood Transfusion. BenefitsRisks Risks & Benefits There is no doubt that Blood Transfusion is an integral part of everyday hospital life and like most.

NIGERIA Country presentation: State of Health Care Financing by Chima A. Onoka and Chijioke I. Okoli Health Policy Research Group University of Nigeria,

European Health Forum 2003Reinhart Waneck1 Safety and Quality of Human Blood Products and Human Blood Derivatives in an Enlarged European Union The experience.

Pharm. Dr. Mrs. C.O. Olumese UBTH Benin City

And the order changeth …. Evolving protocols for TTI testing

THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.

IN THE NAME OF GOD Blood Safety S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO) RESEARCH CENTER June.

February 15-18, 2005 Pension Reform Technical Assistance U. S. Agency for International Development (USAID)

HSA 171 CAR. 1436/ 7/4  The results of activities of an organization or investment over a given period of time.  Organizational Performance: ◦ A measure.

Dr. Christof Veit BQS Institut for Quality and Patient Safety Dusseldorf / Hamburg Quality and Regulation. Experiences from the German Health Care System.

Unit 10. Monitoring and evaluation

Beyond the Pale: the Ethics of Gifts Professor Andrew Zolani Cakana (FIBMS; MB ChB; CTM; M Med Sc.; FRCPath).

The policy development for introducing of the oral fluid based rapid HIV test kit in Thailand Writers in the 2009 Write Workshop (WHO Bulletin)

3 August 2004 Public Health Practice III: FINANCING PUBLIC HEALTH REFORM Thomas E. Novotny MD MPH University of California San Francisco Institute for.

Svetlana Spassova, MD Ministry of Health, Bulgaria Chisinau

World Bank and Statistical Capacity Building PARIS21 Task Team Meeting Washington, DC September 10, 2001.

Pharmaceutical system strengthening – Is there a need for a new paradigm? Andreas Seiter The World Bank ICIUM 2011, Antalya 1.

Monitoring &Evaluation System in Health Program. Brief overview of NACP Reporting units and quality aspects Data sets Learning/ Analysis of the data sets.

Financing for Development United Nations Risk Mitigation for Mobilizing Private Sector Investments in Infrastructure in Developing Countries Pradeep Singh.

Presented by LT COL (DR) PRATIMA SINGH- QCI and NABH CERTIFIED CONSULTANT.

Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006.

National Quality Infrastructure TRTA3 Approach

National Blood Transfusion Policy in Libya: challenges and opportunity. Dr. Abdulmonem Alserraj MSc, MD. Head of National Blood Transfusion committee.

Our tryst with Nucleic Acid Testing Dolly Daniel, Dept of Transfusion Medicine, CMC, Vellore.

K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

BLOOD TRANSFUSION SAFETY: PROGRESS REPORT 142 nd Session of the Executive Committee June 2008, Washington DC Pan American Health Organization 142.

WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.

The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and.

BLOOD TRANSFUSION IN TURKEY. SHORT HISTORY 1921: Prof. Dr. Burhanettin TOKER gave a start to Transfusion works in TURKEY 1938 : First transfusion in Cerrahpasa.

MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH

Prevention of Blood-Borne Pathogen Transmission in Egypt Ministry of Health and Population Arab Republic of Egypt.

Exploring financing options NATIONAL TB CONTROL OF VIETNAM.

Residual Risk and Waste in Donated Blood with Pooled Nucleic Acid Testing Hrayer Aprahamian, Dr. Ebru Bish, Dr. Douglas Bish Virginia Polytechnic Institute.

IHQA.  GUIDELINES REGARDING STAFF RECRUITMENT,CREDENTIALLING,TRAINING,DI SCIPLINE,RIGHTS,DUTIES,HEALTH ISSUES,SERVICE RULES,ETC.

Efficiency, Effectiveness, and Financial Sustainability: The Importance of Country Ownership Dr Bernhard Schwartländer UNAIDS.

Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.

3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.

Ministry’s Vision for Universal Health Coverage Dr San San Aye Director (Planning) Department of Health Planning Ministry of Health National Dialogue on.

Overview of Indonesia HIS Situation Ministry of Health Rahmaniar Brahim Head of Health Statistics Division Centre for Data and Information MoH

Pre-meeting Summary Shannon Barkley, MD MPH Primary Health Care Service Delivery and Safety Department (SDS) World Health Organization 11 April 2016.

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.

Coordinator of Project management Unit of Global fund and MAP projects

8 March 2016 CORPORATE GOVERNANCE IN THE HEALTH SECTOR In association with.

BURUNDI PERMANENT EXECUTIVE SECRETARIAT (SEP) NATIONAL AIDS COUNCIL (C N L S) Epidemic situation and national response for prevention in Burundi PRESENTED.

Draft - Enterprise Risk Management Risk Universe

Title of the Change Project

Taxonomy of Strategies

i2i turning development around

Prevalence of HIV infection among blood donors at the National Blood Transfusion Centre in Bangui, Central African Republic Claudine Bekondi1a, Pulchérie.

Exhibition Conceptualisation & Organisation

AFRICA REGION Achi Atsain (Chair).

Health Inspectorate of Republic of Kosova Work Plan 2019

EuroNHID project Scientific Contents

Impact of quality on day-to-day efforts of PHC

HEALTH SYSTEMS (SECTOR) REFORMS Economic Association of Namibia

Presentation transcript:

NAT as part of routine tests ? I disagree ! Dr Anjali Arun Mysore

Intelligent use of blood Any transfusion has risks The safest blood is the one which is not transfused.

Reducing the Risk of Infection Donor history -deferral Donor examination Testing Diversion Leukoreduction Component inspection Post donation information Donor deferral registries Limit exposures Hemovigilance

What is the best test for HIV, HBV & HCV ? Undoubtedly Nucleic Acid Testing ( NAT)

Stakeholders Blood banks : Government/trust/private/corporate/stand alone/hospital based,etc Policy makers : health ministry,planners, economists, bureaucrats, Implementers: drug control dept Patients, blood donors

Aspects Technical Legal Logistic Financial

Limitations Fragmented blood bank system Repeat voluntary donor mass is less Variable volumes in each centre Infrastructure Health care cost burden: insurance / individual /government (BPL/co-operatives, TPA, CGHS, ESI,etc)

Blood banks: Government /trust / private / corporate / stand alone / hospital based Technical : pooled or single donor, which equipment, work load, TATs, Legal: not yet mandatory Logistic : convince management; recruit train and retain staff or out source,attitudes** Financial : rising cost of components, budgetary constraints

Policy makers Technical : centralized Vs decentralized Legal : StateVs Central Logistic : talent pool availability, training, location, Financial : Equitable distribution of funds, Priorities related to health care and prevention of

Implementers: drug control dept Technical : knowledge pool, training Legal : present framework Logistic : training their staff, numbers Financial : rules regarding charges for components.

Patients, blood donors Technical : want and should get the best Legal : right if made mandatory Logistic……… Financial : market rates for components ?

Best case scenario NAT is legally mandatory Blood banking is cohesive Training is done Logistics is arranged Funding is arranged We are all doing NAT for every unit collected

outcome Window period reduced not eliminated Cost will rise Other measures needed

Blood Safety is a journey, ……………………………. Thank You ! Declaration : Conflict of interest : none